MDPI and ACS Style
Elsherbeny, M.H.; Ammar, U.M.; Abdellattif, M.H.; Abourehab, M.A.S.; Abdeen, A.; Ibrahim, S.F.; Abdelrahaman, D.; Mady, W.; Roh, E.J.; Elkamhawy, A.
Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876. Life 2024, 14, 423.
https://doi.org/10.3390/life14040423
AMA Style
Elsherbeny MH, Ammar UM, Abdellattif MH, Abourehab MAS, Abdeen A, Ibrahim SF, Abdelrahaman D, Mady W, Roh EJ, Elkamhawy A.
Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876. Life. 2024; 14(4):423.
https://doi.org/10.3390/life14040423
Chicago/Turabian Style
Elsherbeny, Mohamed H., Usama M. Ammar, Magda H. Abdellattif, Mohammed A. S. Abourehab, Ahmed Abdeen, Samah F. Ibrahim, Doaa Abdelrahaman, Wessam Mady, Eun Joo Roh, and Ahmed Elkamhawy.
2024. "Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876" Life 14, no. 4: 423.
https://doi.org/10.3390/life14040423
